Details of the Drug

General Information of Drug (ID: DMTLGKX)

Drug Name

JNJ-70218902

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04397276) A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors. U.S. National Institutes of Health.